KOL | Zhongyang ShenOrgan Transplant Center, Tianjin First Central Hospital, Nankai University, Tianjin 300192, PR China; NHC Key Laboratory for Critical Care Medicine, Tianjin First Central ... |
KOL Resume for Zhongyang Shen
| Year | |
|---|---|
| 2022 | Organ Transplant Center, Tianjin First Central Hospital, Nankai University, Tianjin 300192, PR China; NHC Key Laboratory for Critical Care Medicine, Tianjin First Central Hospital, Tianjin 300384, PR China; Tianjin Key Laboratory for Organ Transplantation, Tianjin First Central Hospital, Tianjin 300192, PR China. |
| 2021 | Organ Transplant Center, Tianjin First Central Hospital, School of Medicine, Nankai University, Tianjin, China. |
| 2020 | NHC Key Laboratory for Critical Care Medicine. |
| 2018 | Organ Transplantation Center, The First Central Hospital of Tianjin, Tianjin, China (mainland). |
| 2015 | Department of Transplant Surgery, Tianjin First Central Hospital |
Zhongyang Shen: Influence Statistics
| Concept | World rank |
|---|---|
| foxo1regulated autophagy | #8 |
| β cells hypoxia | #8 |
| hypoxia human islets | #8 |
| sqstm1 expressions | #8 |
| t2dm human pancreases | #8 |
| t2dm hif1α foxo1 | #8 |
| study hif1α foxo1 | #8 |
| hif1α foxo1 axis | #8 |
| t2dm expressions | #10 |
| hif1α foxo1 | #16 |
| islets hif1α | #21 |
| islets cocl2 | #22 |
| sqstm1 key | #22 |
| nonβ endocrine cells | #30 |
| lc3 p62 sqstm1 | #32 |
| tianjin center hospital | #35 |
| cryopreserved iliac | #37 |
| rapid metabolic rate | #46 |
| foxo1 human | #52 |
| autophagy benefits | #54 |
| foxo1 regulated | #61 |
| key autophagy regulators | #73 |
| β cell survival | #94 |
| vein living | #95 |
Open the FULL List in Excel | |
Prominent publications by Zhongyang Shen
Primary liver transplantation and salvage liver transplantation for patients with primary liver cancer
[ PUBLICATION ]
Objective To compare long-term outcome of primary liver transplantation and salvage liver transplantation in treating patients with primary liver cancer, and discuss the clinical feasibility of salvage liver transplantation. Methods We retrospectively analyzed the clinical data of 1 420 patients with primary liver cancer, including 170 cases treated with salvage liver transplantation and 1 250 cases with direct liver transplantation from Transplantation Center of Tianjin First Center ...
| Known for Liver Transplantation | Clinical Data | Survival Curve | Tianjin Center Hospital | 5 Year |
Dynamic Change of β to α Ratio in Islets of Chinese People With Prediabetes and Type 2 Diabetes Mellitus.
[ PUBLICATION ]
OBJECTIVES: The present study aimed to investigate the dynamic change of α cells and β cells, and their ratios in prediabetes and type 2 diabetes in the Chinese population.
METHODS: Pancreata from 27 nondiabetic (ND), 8 prediabetic (PreD), and 19 type 2 diabetic (T2D) organ donors were subjected to immunofluorescence staining with insulin and glucagon.
RESULTS: The β to α ratio in islets (β/α) in PreD was significantly higher than that in ND, resulting from an increase of β cells and a ...
| Known for Β Cells | 2 Diabetes | Immunofluorescence Staining | Organ Donors | Correlated Hba1c |
Complex congenital heart disease and pediatric liver transplantation: case reports and a brief review
[ PUBLICATION ]
Objective To discuss the surgical strategy for children with complex congenital heart disease (CHD) and end-stage liver disease (ESLD). Methods We reported two cases of pediatric liver transplantation in patients with complex CHD and ESLD. Medical data including operation procedure, ICU management and outcomes were reviewed retrospectively. Also we reviewed the literature on the topic of clinical outcomes resulted from different surgery options. Results The first case was a ...
| Known for Liver Transplantation | Post Operative |
Marked improvement in the prognosis for patients with liver cancer who undergo liver transplantation has been achieved as a result of advances in liver transplantation techniques. Given the current shortage of organs in China, a favorable long-term survival rate might be achieved with rigorous selection of suitable patients and therefore benefit society the most. Further study of the mechanism of cancer recurrence following liver transplantation, continuing to optimize pretreatment ...
| Known for Hepatocellular Carcinoma | Treatment Cancer | Liver Neoplasms |
Clinical Analysis of Classification and Prognosis of Ischemia-Type Biliary Lesions After Liver Transplantation.
[ PUBLICATION ]
BACKGROUND The aim of this study was to classify ischemia-type biliary lesions after liver transplantation according to their imaging findings and severity of clinical manifestations and to analyze the relationship between such classification and prognosis. MATERIAL AND METHODS We collected clinical data of patients with ischemia-type biliary lesions (ITBL) after liver transplantation in the Organ Transplantation Center, the First Central Hospital of Tianjin, from August 2012 to July ...
| Known for Liver Transplantation | Type Biliary | Bile Ducts | Rates 1 |
Key People For Liver Transplantation
Zhongyang Shen:Expert Impact
Concepts for whichZhongyang Shenhas direct influence:Liver transplantation, Β cell survival, Primary liver cancer, Human islets, Middle hepatic vein, Β cell, Hepatic vein, Hif1α foxo1.
Zhongyang Shen:KOL impact
Concepts related to the work of other authors for whichfor which Zhongyang Shen has influence:Liver transplantation, Human islets, Β cell dedifferentiation, Reconstruction material, Cytohistologic analyses, Normothermic machine perfusion, Hepatic vein.
Tools
Is this your profile? Claim your profile Copy URL Embed Link to your profile |